We tested the effect of this compound on MLL-rearranged (MV4;11, MOLM13) and non-MLL-rearranged leukemia cell lines (HL-60, K562, Kasumi-1), as well as on normal CD34+ cord blood cells. This evidence concerns the gene CD34 and leukemia.